H.R. 422, a bill to permanently extend and strengthen the federal R & D tax credit
S.1203, the GROWTH Act, a bill to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit
Deferral tax as mentioned in the President's proposed budget for 2010 and as a proposed payment for health reform Senate and House Committee Health Reform bills with an emphasis on physician disclosure, comparative effectiveness research, pain research, bundling and gainsharing                                                                                                                       
S.540, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices
H.R.1346, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices Reform of the 510 (k) regulatory pathway
H.R. 759, Food and Drug Administration Globalization Act, a bill to improve the safety of food, drugs, devices, and cosmetics
S. 882, the Drug and Device Accountability Act, a bill to ensure the safety and quality of medical products and enhance the authorities of the FDA
H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research and create a Comparative Effectiveness Research Trust Fund
S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research and to establish a Patient-Centered Outcomes Research Trust Fund 
H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research relating to health care
S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies
H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies
S.1380, Medicare Payment Advisory Commission (MedPAC) Reform Act , a bill to make the commission an executive branch agency, and provide the Commission new resources and authority to implement Medicare payment policy S.301, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices
H.R. 3138, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices
H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research and create a Comparative Effectiveness Research Trust Fund
S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research and to establish a Patient-Centered Outcomes Research Trust Fund 
H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research relating to health care
S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising
Medicare coverage of PLATINUM clinical trial S.560, the Employee Free Choice Act, a bill to establish an efficient system to enable employees to form, join, or assist labor organizations and to provide for mandatory injunctions for unfair labor practices during the organizing efforts
H.R. 1409, the Employee Free Choice Act, a bill to establish an efficient system to enable employees to form, join, assist labor organizations, and to provide for mandatory injunctions for unfair labor practices during the organizing efforts HR. 2454, American Clean Energy and Security Act, a bill to create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy
S.5 a bill to reduce the dependence on foreign and unsustainable energy sources and risks of global warming Over the Counter Derivatives, provisions related to changing the regulation S.515. Patent Reform Act of 2009, provisions related specifically to innovative technologies
H.R. 1260, Patent Reform Act of 2009, provisions related specifically to innovative technologies Market Access, regulatory approvals and reimbursement for medical devices in Japan, EU, Korea, China, Brazil
Trade agreements with Columbia and South Korea
TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid LBR - Labor Issues/Antitrust/Workplace NAT - Natural Resources FIN - Financial Institutions/Investments/Securities CPT - Copyright/Patent/Trademark TRD - Trade (domestic/foreign)
136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR)
BOSTON SCIENTIFIC CORPORATION
1455 PENNSYLVANIA AVENUE, NW, SUITE 925, WASHINGTON, DC, 20004, US
STEVEN NEIL LAPIERRE MICHAEL MATTOON BRENDA BECKER JEAN CECIL FRICK STEVEN NEIL LAPIERRE SCOTT REID MICHAEL MATTOON BRENDA BECKER JEAN CECIL FRICK STEVEN NEIL LAPIERRE MICHAEL MATTOON SCOTT REID BRENDA BECKER STEVEN NEIL LAPIERRE MICHAEL MATTOON BRENDA BECKER JEAN CECIL FRICK STEVEN NEIL LAPIERRE MICHAEL MATTOON BRENDA BECKER STEVEN NEIL LAPIERRE MICHAEL MATTOON BRENDA BECKER STEVEN NEIL LAPIERRE MICHAEL MATTOON BRENDA BECKER STEVEN NEIL LAPIERRE MICHAEL MATTOON BRENDA BECKER